Camosunate Paediatric Powder – For Infants 0-11 Months

Effective Treatment for Uncomplicated Malaria in Infants

Camosunate Paediatric Powder is a combination antimalarial medication specifically formulated for infants aged 0 to 11 months. It contains Artesunate (25 mg) and Amodiaquine (75 mg) per sachet, providing a potent treatment against Plasmodium falciparum malaria.

Key Features

• Artemisinin-Based Combination Therapy (ACT): Combines Artesunate and Amodiaquine, as recommended by the World Health Organization (WHO) for effective malaria treatment.

• Infant-Specific Dosage: Each sachet is precisely dosed for infants, ensuring safety and efficacy.

• Easy Administration: Powder formulation allows for simple preparation and administration to young children.

Indications

• Treatment of Uncomplicated Malaria: Effective against P. falciparum, including strains resistant to other antimalarial drugs.

Dosage and Administration

• Dosage: Administer one sachet daily for three consecutive days.

• Preparation: Dissolve the contents of one sachet in a small amount of clean water or milk to create a suspension.

• Administration: Ensure the child consumes the entire prepared dose immediately after preparation.

• Completion of Therapy: It is crucial to complete the full three-day course, even if symptoms improve earlier, to ensure the elimination of the malaria parasite.

Precautions

• Medical Supervision: Use under the guidance of a healthcare professional.

• Allergies: Do not use if the infant has known hypersensitivity to Artesunate, Amodiaquine, or any other components of the medication.